A Prospective Phase II Trial Of Molecular Profiling To Guide Neoadjuvant Therapy For Resectable And Borderline Resectable Adenocarcinoma Of The Pancre
Posted Date: May 15, 2019
- Investigator: Syed Ahmad
- Type of Study: Observational/Survey
You are being asked to take part in this study because you are scheduled to have a procedure called EUS/FNA (Endoscopic Ultrasound-guided Fine Needle Aspiration) which is a biopsy of the pancreas. This procedure is being done because you have a pancreas tumor, and a sample of the tumor is needed to
Criteria:
To Be Eligible For This Study, Patients Must Have Resectable Or Borderline Resectable Adenocarcinoma
Keywords:
Mcw Biomarker, Cancer, Pancreas , Pancreatic Cancer
For More Information:
Uc Cancer Center
513-584-7698
kastla@uc.edu